Cargando…
863. Pre-Exposure Prophylaxis (PrEP) Prescriptions among Individuals at High Risk for HIV in the United States, 2012-2018
BACKGROUND: To describe trends in emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) PrEP uptake in 2012-2018 and characterize high risk individuals who use PrEP. METHODS: The study identified individuals aged ≥ 15 years old with claims suggesting high risk for HIV infection in the IBM Market...
Autores principales: | Zhou, Mo, Song, Yan, Gao, Emily, Whiteside, Yohance, Billmyer, Emma, Signorovitch, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644933/ http://dx.doi.org/10.1093/ofid/ofab466.1058 |
Ejemplares similares
-
Patterns of Pre-exposure Prophylaxis (PrEP) Use in a Population Accessing PrEP in Jackson, Mississippi
por: Chase, Erin, et al.
Publicado: (2022) -
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
por: Puro, Vincenzo, et al.
Publicado: (2013) -
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
por: Nozza, Silvia, et al.
Publicado: (2022) -
Configuring the PrEP user: framing pre-exposure prophylaxis in UK newsprint 2012–2016
por: Young, Ingrid, et al.
Publicado: (2021) -
Utilizing emergency departments for pre‐exposure prophylaxis (PrEP)
por: Shull, Jordan A., et al.
Publicado: (2020)